Insider trades
Townsend Richard Nolan, CEO of Lexeo Therapeutics LXEO, has filed 0 purchases and 22 sales on the open market. Over the past 12 months that comes to a net sale of $522.7K. The latest trade was on 09/24.
Townsend Richard Nolan
CEO
- Company
- Lexeo Therapeutics LXEO
- First filing
- 24/01/09
- Trades
- 50 trades
- Buys / sales
- 0 / 22
- 12-month net buying
- −$522.7K
- Last trade
- 09/24
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 05/18 | 05/20 | 3,342 sh | $5.06 | $16,910.52 | −1.0% | |
| Open-market sale10b5-1 plan | 04/06 | 04/07 | 55,000 sh | $5.69 | $312,950 | −13.9% | |
| Open-market sale | 02/18 | 02/20 | 10,173 sh | $6.38 | $64,903.74 | −2.5% | |
| Open-market sale | 25/11/18 | 25/11/20 | 1,127 sh | $9.27 | $10,447.29 | −0.5% | |
LXEO | Open-market sale | 25/10/17 | 25/10/17 | 13,133 sh2 trades | $8.95avg. | $117,500.78 | −5.1% |
| Open-market saleAmendment | 25/08/18 | 25/09/10 | 1,115 sh | $4.67 | $5,207.05 | −0.5% | |
| Open-market sale | 25/08/18 | 25/08/20 | 2,735 sh | $4.67 | $12,772.45 | −1.2% | |
| Open-market sale | 25/05/16 | 25/05/20 | 1,074 sh | $2.77 | $2,974.98 | −0.5% | |
| Open-market sale | 25/02/19 | 25/02/21 | 4,326 sh | $4.41 | $19,077.66 | −1.9% | |
| Open-market sale10b5-1 plan | 24/12/10 | 24/12/12 | 2,500 sh | $8.20 | $20,500 | −2.0% | |
| Open-market sale10b5-1 plan | 24/11/11 | 24/11/13 | 2,500 sh | $7.82 | $19,550 | −2.0% | |
| Open-market sale10b5-1 plan | 24/10/10 | 24/10/15 | 5,000 sh | $8.10 | $40,500 | −4.0% | |
| Open-market sale10b5-1 plan | 24/09/10 | 24/09/11 | 5,000 sh | $10.65 | $53,250 | −4.0% | |
| Open-market sale10b5-1 plan | 24/08/12 | 24/08/13 | 5,000 sh | $11.53 | $57,650 | −4.0% | |
LXEO | Open-market sale10b5-1 plan | 24/07/10–24/07/11 | 24/07/12 | 55,000 sh4 trades | $16.79avg. | $923,387.71 | −31.3% |
LXEO | Open-market sale10b5-1 plan | 24/06/10 | 24/06/12 | 5,000 sh2 trades | $17.65avg. | $88,263.82 | −2.8% |
| Open-market sale10b5-1 plan | 24/05/13 | 24/05/14 | 5,000 sh | $13.22 | $66,100 | −2.8% |